Company Analysis

Alector, Inc. (ALEC)

Nasdaq: ALEC · Biological Products, (No Diagnostic Substances) · South San Francisco, CA · filing with the SEC since 2015
Grade3.8
◀ Past 5.9● Present 4.0▶ Future 2.2
1 est.

Who runs Alector, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Rosenthal Arnon
Chief Executive Officer. First filing Feb 2019, latest Oct 15, 2026, 21 filings in all.
Officers reporting now
4
of 11 people with a filing in the last fifteen months
Directors reporting now
7
26 people on the record since 2019
Officerssales are open-market, Oct 15, 2025 to Oct 15, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Rosenthal ArnonChief Executive OfficerFeb 2019Oct 15, 20264 · $700,000
Berkley Neil LindsayCFO & Chief Business OfficerJun 2025Oct 15, 20264 · $200,000
Wong-Sarad GracePrincipal Accounting OfficerJun 2025Oct 15, 202612 · $100,000
Kenkare-Mitra SaraPresident and Head of R&DDec 2021Dec 3, 20251 · $0.00
Directorssales are open-market, Oct 15, 2025 to Oct 15, 2026
NameRoleFirst filingLatest filingSales, 12 months
Altmeyer MarkdirectorMar 2024Jun 17, 2026none
Desouza Errol BdirectorMar 2024Jun 17, 2026none
Garofalo Elizabeth A.directorSep 2021Jun 17, 2026none
Hammond PauladirectorMar 2020Jun 17, 2026none
Lavigne Louis J JrdirectorFeb 2019Jun 17, 2026none
Scheller Richard HdirectorFeb 2019Jun 17, 2026none
Yaffe KristinedirectorAug 2019Jun 17, 2026none
Earlier names on the record20, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton ALEC · research, not advice